HEALTH CATALYST INC
HCATNASDAQ🏆 #3890 by market capEarnings Nov 5US Equity
$1.80▼ $0.01 (−0.55%)
🌙 After hours$1.79▼ 0.56%Regular close · extended-hours price shownTrack HCAT
Get earnings, price moves & breaking news on Telegram
24h▼ 0.6%
7d▲ 3.4%
14d▼ 0.6%
30d▲ 2.9%
ytd▼ 24.7%
1y▼ 46.2%
🏦Market Cap
$135M
Small Cap
📈Revenue Growth (YoY)
-7.5%
Declining
📊Gross Margin
51.2%
Healthy
💵FCF Margin
5.9%
Moderate
⚖️P/S Ratio
0.4x
Cheap
Otter Score
—
Insufficient data
HEALTH CATALYST INC
HCATAnalyst Ratings
Price
$1.80
Total
22
Raised
2
Lowered
3
Avg PT
$1.77
H / L
$2 / $2
| Institution | Action | Rating | Date | Upside | |
|---|---|---|---|---|---|
Canaccord Genuity | Downgraded | Buy → Hold | 2026-08-21 | $1.80 | +0.00% |
Wells Fargo | Reiterated | Equal Weight | 2026-08-13 | $1.75 | −2.80% |
Citigroup | Reiterated | Neutral | 2026-08-11 | — | — |
Stephens & Co. | Reiterated | Equal Weight | 2026-05-12 | — | — |
Cantor Fitzgerald | Reiterated | Neutral | 2026-03-13 | $60.00 | +3233.30% |
Stifel | Reiterated | Hold | 2026-03-13 | — | — |
Keybanc | Reiterated | Overweight | 2025-10-08 | $4.00 | +122.20% |
Evercore ISI Group | Reiterated | In Line | 2025-10-08 | — | — |
BTIG | Reiterated | Neutral | 2025-09-05 | — | — |
Piper Sandler | Downgraded | Overweight → Neutral | 2025-08-27 | $11.00 | +511.10% |
RBC Capital | Reiterated | Sector Perform | 2025-02-27 | $7.00 | +288.90% |
JP Morgan | Reiterated | Overweight | 2024-09-04 | — | — |
Guggenheim | Upgraded | Neutral → Buy | 2024-01-26 | $14.00 | +677.80% |
Raymond James | Downgraded | Strong Buy → Market Perform | 2023-05-10 | $3.00 | +66.70% |
SVB Leerink | Reiterated | Outperform | 2022-11-09 | — | — |
Goldman Sachs | Reiterated | Buy | 2022-08-10 | $48.00 | +2566.70% |
Jefferies | Upgraded | Hold → Buy | 2022-03-17 | — | — |
Berenberg | Reiterated | Buy | 2020-12-08 | — | — |
Truist Securities | Reiterated | Buy | 2020-08-12 | — | — |
SunTrust Robinson Humphrey | Reiterated | Buy | 2020-05-13 | — | — |
Piper Jaffray | Reiterated | Overweight | 2019-08-19 | — | — |
William Blair | Reiterated | Outperform | 2019-08-19 | — | — |
Institution
Canaccord Genuity
Downgraded · Buy → Hold · 2026-08-21
$1.80
+0.00%
Wells Fargo
Reiterated · Equal Weight · 2026-08-13
$1.75
−2.80%
Citigroup
Reiterated · Neutral · 2026-08-11
—
—
Stephens & Co.
Reiterated · Equal Weight · 2026-05-12
—
—
Cantor Fitzgerald
Reiterated · Neutral · 2026-03-13
$60.00
+3233.30%
Stifel
Reiterated · Hold · 2026-03-13
—
—
Keybanc
Reiterated · Overweight · 2025-10-08
$4.00
+122.20%
Evercore ISI Group
Reiterated · In Line · 2025-10-08
—
—
BTIG
Reiterated · Neutral · 2025-09-05
—
—
Piper Sandler
Downgraded · Overweight → Neutral · 2025-08-27
$11.00
+511.10%
RBC Capital
Reiterated · Sector Perform · 2025-02-27
$7.00
+288.90%
JP Morgan
Reiterated · Overweight · 2024-09-04
—
—
Guggenheim
Upgraded · Neutral → Buy · 2024-01-26
$14.00
+677.80%
Raymond James
Downgraded · Strong Buy → Market Perform · 2023-05-10
$3.00
+66.70%
SVB Leerink
Reiterated · Outperform · 2022-11-09
—
—
Goldman Sachs
Reiterated · Buy · 2022-08-10
$48.00
+2566.70%
Jefferies
Upgraded · Hold → Buy · 2022-03-17
—
—
Berenberg
Reiterated · Buy · 2020-12-08
—
—
Truist Securities
Reiterated · Buy · 2020-08-12
—
—
SunTrust Robinson Humphrey
Reiterated · Buy · 2020-05-13
—
—
Piper Jaffray
Reiterated · Overweight · 2019-08-19
—
—
William Blair
Reiterated · Outperform · 2019-08-19
—
—
One row per institution · price target from the firm's latest published target
StockOtter · stockotter.space